Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

DNA damage response and hematological malignancy.

Masatoshi Takagi1

  • 1Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University (TMDU), Yushima 1-5-45, Bunkyo-ku, Tokyo, 113-8519, Japan. m.takagi.ped@tmd.ac.jp.

International Journal of Hematology
|April 5, 2017
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Role of Hematopoietic Cell Transplantation in Ataxia-Telangiectasia.

Pediatric blood & cancer·2026
Same author

Polyclonal evolution of lymphoproliferative disorders in XLP1.

Journal of human immunity·2026
Same author

Clinical Usefulness of Selective Plasma Exchange for Treating Pediatric Autoimmune Neurological Diseases.

Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·2026
Same author

Multi-omics analysis identifies an M-MDSC-like immunosuppressive phenotype in lineage-switched AML with KMT2A rearrangement.

Nature communications·2025
Same author

Trajectories from single-cells to PAX5-driven leukemia reveal PAX5-MYC interplay in vivo.

Leukemia·2025
Same author

Monitoring measurable residual disease in NUP98::NSD1-positive acute myeloid leukemia.

Pediatrics international : official journal of the Japan Pediatric Society·2025

DNA damage threatens cell stability, triggering the DNA damage response (DDR) and repair mechanisms. Understanding DDR is crucial for preventing cancer and developing new therapies.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cancer Research

Background:

  • DNA damage poses a significant risk to cellular homeostasis, potentially causing genomic instability, mutations, senescence, or cell death.
  • The DNA damage response (DDR) is a critical cellular process activated by DNA damage, initiating DNA repair pathways.
  • Dysregulation of DDR is implicated in cancer development and progression.

Purpose of the Study:

  • To elucidate the fundamental mechanisms of the DNA damage response (DDR) and DNA repair pathways.
  • To explore the role of DDR in maintaining cellular homeostasis and preventing cancer.
  • To highlight the therapeutic potential of targeting DDR and DNA repair in cancer treatment.

Main Methods:

  • Review of existing literature on DNA damage, DDR, and DNA repair mechanisms.
Keywords:
ATMCaner susceptible syndromeDNA damage responseDNA repairHematological malignancy

Related Experiment Videos

  • Analysis of the implications of germ line and somatic mutations in DDR-associated genes.
  • Examination of current and emerging therapeutic strategies targeting DDR and DNA repair.

    • Main Results:

    • DNA damage triggers a complex DDR cascade involving multiple signaling pathways and repair enzymes.
    • Defects in DDR genes are linked to cancer-susceptible syndromes and are frequently observed in various tumors.
    • Targeting DDR and DNA repair pathways presents a promising avenue for novel cancer therapies.

    Conclusions:

    • A comprehensive understanding of DDR and DNA repair mechanisms is essential for advancing cancer etiology knowledge.
    • Targeting DDR offers a strategic approach to developing more effective cancer treatments.
    • Further research into DDR pathways will facilitate the development of innovative cancer therapies.